Citadel Advisors - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 115 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q3 2023$854,734
+149.2%
22,666
+98.4%
0.00%
Q3 2022$343,000
-47.5%
11,425
-36.7%
0.00%
Q2 2022$653,000
+11.2%
18,047
+32.8%
0.00%
Q1 2022$587,000
-35.8%
13,589
-25.6%
0.00%
Q4 2021$915,000
+139.5%
18,255
+204.0%
0.00%
Q3 2021$382,000
-76.7%
6,005
-73.2%
0.00%
Q4 2020$1,643,000
-40.0%
22,378
-55.2%
0.00%
-100.0%
Q3 2020$2,737,000
-53.6%
49,898
-43.7%
0.00%
-50.0%
Q2 2020$5,895,000
-50.1%
88,659
-54.0%
0.00%
-60.0%
Q1 2020$11,803,000
+132.1%
192,863
+233.4%
0.01%
+150.0%
Q4 2019$5,086,000
-7.9%
57,845
-20.9%
0.00%
-33.3%
Q3 2019$5,520,000
+42.2%
73,166
+61.0%
0.00%
+50.0%
Q2 2019$3,881,000
-13.4%
45,433
+9.5%
0.00%0.0%
Q1 2019$4,483,000
-35.4%
41,475
-49.4%
0.00%
-50.0%
Q4 2018$6,942,000
+57.2%
82,016
+82.5%
0.00%
+100.0%
Q3 2018$4,417,000
+649.9%
44,928
+652.8%
0.00%
Q1 2018$589,000
-6.4%
5,968
+6.2%
0.00%
-100.0%
Q2 2017$629,000
-25.7%
5,617
-30.2%
0.00%0.0%
Q4 2016$847,000
+46.3%
8,050
+99.1%
0.00%0.0%
Q1 2016$579,000
-60.2%
4,044
-60.8%
0.00%0.0%
Q1 2015$1,454,000
+73.3%
10,308
+89.2%
0.00%0.0%
Q3 2014$839,000
+62.9%
5,449
+17.4%
0.00%0.0%
Q1 2014$515,0004,6420.00%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q3 2018
NameSharesValueWeighting ↓
Claret Asset Management Corp 86,474$6,524,0001.34%
Analyst IMS Investment Management Services Ltd. 28,438$2,143,0000.64%
ALGERT GLOBAL LLC 20,876$1,575,0000.59%
Quantinno Capital Management LP 9,351$706,0000.48%
Crestline Management, LP 37,000$2,792,0000.45%
Empirical Finance, LLC 9,561$721,0000.20%
BRANDES INVESTMENT PARTNERS, LP 55,065$5,469,0000.14%
FORT, L.P. 9,672$730,0000.14%
CAXTON ASSOCIATES LP 8,865$669,0000.13%
ACADIAN ASSET MANAGEMENT LLC 330,448$24,928,0000.11%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders